Vienna, Austria – November 3, 2025 – Noselab participated in this year’s BIO-Europe event, held from November 3 to 5, 2025, in Vienna, showcasing our commitment to pioneering a non-invasive window to the brain and leveraging the brain-nose interface to advance disease understanding, diagnosis, and treatment.
Represented by Marion San Nicoló, MD and Dr. Peter Fruhstorfer, Noselab engaged with fellow scientific experts and biopharma professionals at the esteemed event. Based on our revolutionary diagnostic platform, we introduced our latest innovations in healthcare and medical breakthroughs.
BIO-Europe represents Europe’s flagship partnering event for professionals, bringing together thousands of participants from across the global biotechnology and pharmaceutical community.
With increasing attention on brain disorders and the urgent need for early diagnostic solutions, Noselab’s technology resonated strongly throughout the event. Across the three-day event, Noselab participated in dedicated partnering meetings and expert exchanges focused on the future of neurological disease management, biomarker development, and precision medicine. The team emphasized the importance of interdisciplinary collaboration to accelerate the translation of scientific discovery into real-world clinical benefit.
Looking ahead, Noselab will continue advancing its research and clinical validation efforts in collaboration with global partners. Additional updates on further milestones, clinical study timelines, and strategic collaborations will be shared as progress continues.
For those who were unable to attend, Noselab welcomes further dialogue with partners interested in advancing non-invasive neurological diagnostics and clinical development.
Learn more about Noselab GmbH and our upcoming event – the Brain-Nose Symposium.